• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Natural polysaccharide-based smart CXCR4-targeted nano-system for magnified liver fibrosis therapy

    2024-04-05 02:28:24LiqiongSunXinpingLuoChenxiZhouZhanweiZhouMinjieSun
    Chinese Chemical Letters 2024年2期

    Liqiong Sun ,Xinping Luo ,Chenxi Zhou ,Zhanwei Zhou,* ,Minjie Sun,*

    a College of Horticulture,Nanjing Agricultural University,Nanjing 210095,China

    b NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients,State Key Laboratory of Natural Medicines,Department of Pharmaceutics,China Pharmaceutical University,Nanjing 210009,China

    Keywords: Nanoparticle CXCR4 antagonism ROS-responsive Hepatic stellate cells Liver fibrosis

    ABSTRACT Activated hepatic stellate cells (aHSCs),the main source of extracellular matrix deposition,are key targets in liver fibrosis.However,no effective drug specific to aHSCs has been clinically applied due to poor drug delivery efficiency.Herein,we designed a CXC chemokine receptor 4 (CXCR4)-targeted reactive oxygen species (ROS)-responsive platform AMD-Dex-ROS-responsive-sorafenib (ARS) based on natural polysaccharide and thioctic acid frame,which can deliver anti-fibrosis drug represented by sorafenib specifically to aHSCs on account of CXCR4 over-expression on aHSCs,and smartly disassemble via ROS-responsive thioketal rupture relying on high intracellular ROS in HSCs,realized on-demand drug release and effective liver fibrosis reversion.Notably,in this platform,the CXCR4 antagonist AMD3100 not only enhanced aHSCs targeting efficiency of sorafenib but also effectively magnified the aHSCs elimination of sorafenib by blocking stroma cell derived factor-1 (SDF-1)/CXCR4-induced aHSCs protection,resulting in synergistic anti-fibrosis effect.The platform provided a new approach for drug delivery system design and liver fibrosis treatment.

    Liver fibrosis,precursor of liver cirrhosis and hepatocellular carcinoma (HCC),typical for hindered liver function and expanded extracellular matrix production,essentially collagens,has been a global health problem without approved treatment [1].As a central contributor to collagen deposition,activated hepatic stellate cells(aHSCs) play a pivotal role in the development of liver fibrosis and represent a potential therapeutic target [2].In recent study,several therapies proposed for liver fibrosis are promising,among which the most eye-catching one is targeting for aHSCs,including inhibiting their activation or inducing their apoptosis [3].

    However,the efficacy of HSC-targeted therapy is hampered by poor drug delivery and complicated microenvironments of the fibrotic liver [4-6],where various cells gathered and regulated the fibrosis process such as Kupffer cells,hepatocytes and liver sinusoidal endothelial cells.According to recent studies [7-9],the tendency of nanoparticles to accumulate in the liver make them ideal candidates for treating liver diseases and the targeting moiety can be decorated on the surface of nanoparticles for targeting specific cells,so the potential of nanoparticles for liver fibrosis treatment was highlighted,but there was still long way to go for efficient drug delivery and clinical application.Designing an elaborate nanosystem with higher selectivity specific to aHSCs and intelligent ondemand drug release is still an intractable challenge.

    Elevating the selectivity of drug delivery system on HSCs is a crucial strategy for aHSC-targeting therapy [10-12].CXC receptor 4(CXCR4) is a transmembrane protein overexpressing on the surface of aHSCs,whose binding with its unique ligand stroma cell derived factor-1 (SDF-1) seriously contributing to HSC activation,fibrogenesis,and proliferation [13-16].Therefore,introduction of CXCR4 antagonist on the surface of nano-system could not only enhance selectivity on HSCs and at the mean time reduce SDF-1/CXCR4-induced HSC activation and proliferation.

    Otherwise,the cytotoxicity of drug on normal hepatocyte or other cells emphasize the urgent need to develop safer system which represents selective drug release [17-19,20].High reactive oxygen species (ROS) production especially H2O2during liver fibrosis in aHSCs was discovered [21],which plays an important role in the pathogenesis of liver fibrosis,activating redox-sensitive intracellular pathways in HSCs to increase collagen synthesis [22].The elevated ROS level in aHSCs has the potential to be a sensitive trigger for controlled drug release in pathological microenvironments,and can therefore be used to develop site-specific drug delivery system [23].

    Herein,we designed a multifunctional aHSC-targeting nanoparticle based on natural polysaccharide in order to fully stimulate the anti-fibrotic effect of sorafenib and reduce the unwanted side effect and cytotoxicity (Scheme 1).CXCR4 antagonist AMD3100 served not only as a competitive ligand for targeting aHSCs but also as a therapeutic agent for restraining HSCs activation.In order to reduce unwanted release in other cells,ROS-responsive degradable thioketal group was introduced into the nanoparticlesviareconstructing natural thioctic acid,contributing to on-demand sorafenib release in high-ROS aHSCs.Above all,a smart delivery system with both targeting and responsive release capabilities was skillfully constructed for magnified liver fibrosis treatment.

    Scheme 1.Schematic illustration of the preparation and the effect mechanism of CXCR4-targeting nano-system based on ROS responsive natural polysaccharide conjugate for amplifying liver fibrosis therapy.

    Natural polysaccharides are highly biocompatible and universal in nano-system design due to their biosecurity and easilymodified hydroxyl groups [24,25].So a representative polysaccharide dextran was chosen as a nano-system frame here.First,ROSresponsive amphiphilic conjugate dextran-ROS-responsive thioctic acid derivative (Dex-RTA) was synthesized as described in methods and Fig.S1 (Supporting information).The first step is the reduction of thioctic acid.The presence of the two-SH proton peaks at 1.28 and 1.32 ppm in the1H nuclear magnetic resonance (NMR)spectroscopic analysis indicated the successful reduction of thioctic acid and the production of the reductive product of thioctic acid dihydro thioctic acid (DHTA) (Fig.S2A in Supporting information).Secondly,the ROS-responsive thioctic acid derivative RTA was synthesized through a condensation reaction of DHTA and 2,2-methylpropane and identified by the presence of thioketal group corresponding to the proton peak at 1.58 ppm (Fig.S2B in Supporting information).Thirdly,the signals atδ=1.75 ppm (RTA) andδ=4.68 ppm (anomeric proton in dextran) not only verified the successful synthesis of Dex-RTA but also determined the degree of substitution (DS) of RTA was 55,which was defined as the number of RTA units per 100 anhydroglucosidic (AHG) units (Fig.S2C in Supporting information).

    At the same time,the non-ROS-responsive dextran-lauric acid(Dex-LA) which possessed a similar structure with Dex-RTA except for the thioketal group at the end of the hydrophobic substituent was also synthesized by esterification reaction between dextran and lauric acid.The DS of Dex-LA was determined by the anomeric proton in dextran at 4.68 ppm and the -CH3proton peaks in lauric acid at 0.86 ppm,whose value was 54 similarly as that of Dex-RTA(Fig.S2C).

    As known,amphiphilic conjugates could self-assemble into nano-sized micelles [26].So after the synthesis of Dex-RTA and Dex-LA,nano-systems loaded sorafenib were prepared through solvent exchange method,forming Dex-RTA-Sora nanoparticles(RS NPs) and Dex-LA-Sora nanoparticles (LS NPs),respectively.Their particle size was characterized.Sorafenib-loading enhanced the hydrophobic force of hydrophobic core so that the particle size of Dex-RTA-Sora NPs (RS) decreased than Dex-RTA NPs,from 101.80±3.74 nm to 93.74±3.52 nm (Fig.1A).After AMD3100-adsorption,there was also slight decrease on particle size maybe because the electrostatic interaction between dextran and AMD3100 made the particles more tightly,from 93.74±3.52 nm to 91.28±4.56 nm.What is more,the particle size of ARS nanoparticles was smaller than AMD-Dex-LA-Sora(ALS) nanoparticles,91.28±4.56 nm and 117.30±3.49 nm,respectively,maybe because the cross-linking of thioketal group made the nanoparticles more tightly.At the same time,absorption of AMD3100 caused a marked charge reversal on the surface of the RS NPs (Fig.1B),further proving that the positively-charged AMD3100 binds to the negatively-charged surface of the dextran nanoparticles by electrostatic interactions to form AMD-dextran nanoparticles.

    Fig.1.(A) Particle size of Dex-RTA,RS,ARS and ALS NPs.(B) Zeta potential of RS and ARS NPs.(C) Particle size of ARS NPs before or after 1 mmol/L H2O2 treatment.(D) Transmission electron microscope (TEM) images of ARS NPs before or after 1 mmol/L H2O2 treatment.Scale bar=100 nm.(E) Cumulative release of sorafenib after 1 mmol/L H2O2 treatment.(F) Size stability of ARS NPs in phosphate buffer solution (PBS) and 10% fetal bovine serum (FBS) solution.

    Drug loading capacity (DL) and encapsulation efficiency (EE) of sorafenib in ARS NPs was measured and the results showed that the most efficient loading with a highest encapsulation efficiency of 77.23% ± 5.07% at the ratio of Dex-RTA:sorafenib is 1:0.2 (Fig.S3 in Supporting information).The DL is higher when the feeding ratio is up to 1:0.4,however,the lower EE of 1:0.4 ratio recommended us to choose the 1:0.2 ratio.The DL and EE of ARS are both higher than those of ALS,indicating tighter binding force in ARS than ALS,due to the crosslinking of thioketal bond in ARS NPs.

    Next,ROS-responsive property of ARS NPs was verified from multiple respects.Primarily,ROS-responsive ARS NPs disassembly was confirmed by size and morphology change.The transmission electronic microscope images revealed that the ARS NPs were spherical with a black corona at the outermost layer,indicating the successful adsorption of AMD3100,whereas after H2O2-treatment disruption occurred and size distribution turned into no longer uniform (Figs.1C and D).Besides,the absence of thioketal group after H2O2-treatment in1H NMR spectrum also demonstrated the structure reorganization of ARS NPs (Fig.S2C).

    When the hydrophobic thioketal group converted into hydrophilic -SH as schemed in Fig.S1 (Supporting information),the hydrophobic core was destructed,promoting the release of hydrophobic drug.So,then,the cumulative release of sorafenib in ARS NPs was detected by dialysis method.The red line in Fig.1E showed more release of sorafenib in ARS in the presence of 1 mmol/L H2O2,indicating the ROS-responsive drug release of ARS NPs.

    Then,the size stability of ARS NPs was investigated in PBS solution or 10% FBS solution.As shown in Fig.1F,the particle size of ARS NPs maintained below 150 nm at least within 48 h.

    As widely reported [14,27],CXCR4 is a chemokine receptor overexpressed on the cell surface of aHSCs during the progression of liver fibrosis which is induced by various cellular stress,promoting the activation of HSCs.Thus,we endowed CXCR4-targeted capability to our NPs by decorating CXCR4 antagonist AMD3100 on the surface of NPs,in order to target aHSCs more selectively in fibrotic liver.In order to verify the aHSC-targeting capacity of ARS NPs,two aspects need to be detected.First,in cellular level,the uptake in HSCs of AMD3100-modified NPs should be stronger than NPs without AMD3100-modification;second,the uptake of AMD3100-modified NPs should be stronger in fibrotic livers than healthy livers due to the higher expression of CXCR4 in fibrotic livers than healthy livers.

    At first,we examined whether AMD3100 modification enhanced the intracellular uptake of nanoparticles in aHSCs.Using hydrophobic coumarin 6 (C6) as a tracer molecule,ARC (AMDDex-ROS-responsive-C6) nanoparticles with same characteristics as ARS nanoparticles were prepared (Fig.S4 in Supporting information).Subsequently,we found that the uptake of ARC nanoparticles modified with AMD3100 was significantly enhanced in aHSCs compared with non-targeted Dex-ROS-responsive-C6 (RC) nanoparticles (Fig.2A,Figs.S5 and S6 in Supporting information).What is more,the uptake of ARC nanoparticles by HSCs was competitively inhibited by addition of free AMD3100 in advance,indicating that the nanoparticle targeted uptake was mediated by the CXCR4 over-expression in HSCs.Hence,the HSCs targetinginvitrocould be proved by these results.

    Then,we further detected the HSCs targeting ability of ARC NPsinvivoby evaluating if AMD3100-modified NPs exhibited enhanced liver uptake in CCl4-treated mice than normal mice.All animals received humane care in compliance with the “Guide for the Care and Use of Laboratory Animals” published by the China Pharmaceutical University,and all study procedures and protocols were approved by the Animal Research Committee of China Pharmaceutical University.Chronic liver fibrosis mice model induced by continual CCl4intraperitoneal injection was established as portrayed in Fig.2B,then biodistribution of C6 was detected by liver tissue immunofluorescent staining 4 h after intravenous (I.V.) injection.α-Smooth muscle actin (α-SMA) was labelled as a marker of activated HSCs.According to Fig.2C and Fig.S7 (Supporting information),in frozen liver tissue sections of CCl4model mice,obvious co-localization of green C6 signal and redα-SMA signal in ARC group represented the HSCs targeting of ARC NPs.Consistently,the more tissue distribution of C6 in fibrotic liver in ARC group than normal liver was also observed according to Fig.S8 (Supporting information).Taken together,similar to theinvitroresults,there was increased intracellular uptake of the NPs in the fibrotic livers,indicating that the CXCR4 antagonist AMD3100 can act as a targeting moiety for specific liver delivery.

    Furthermore,not only as a targeting moiety,AMD3100 also exhibited strong synergistic effect with sorafenib on HSCs depletion.Firstly,the cytotoxicity of AMD-Dex-RTA vector was excluded as shown in Fig.3A,proving the biocompatibility and biosafety of vector for various cells in liver,such as hepatocytes,macrophages and HSCs.Next,AMD3100-modified ARS NPs exerted greater cytotoxicity on activated HSCs compared with RS NPs in Fig.3B.What is more,the addition of AMD3100 enhanced the pro-apoptosis effect of sorafenib on HSCs according to Fig.3C and Fig.S9 (Supporting information),and after construction of ARS NPs,the promoting effect of AMD3100 was even stronger.Hence,AMD3100 not only enhanced HSC targeting but also magnified the sorafenib cytotoxicity on HSCs.

    Next,the synergistic mechanism of AMD3100 on HSCs elimination was explored.Indeed,the sensitizing effect of AMD3100 for sorafenib treatment was probably not caused by direct cytotoxicity of AMD3100,according to the safety of AMD-Dex-RTA vector in Fig.3A.Previous study has reported that binding of CXCR4 and its receptor SDF-1 promoted proliferation and activation of HSCs [27],probably providing protective effect for HSCs against sorafenib.To determine this,we exposed HSC-T6 cell lines to recombinant SDF-1 in advance before sorafenib treatment and explored the protective effect of SDF-1 for HSCs.We found that SDF-1 increased the viability of HSCs despite 0 μg/mL (grayvs.red column) or 2 μg/mL(yellowvs.orange column) sorafenib treatment (Fig.3D).However,the addition of AMD3100 did not represent obviously increased HSCs cytotoxicity at the absence of SDF-1 (yellowvs.green column).Then,the CXCR4 antagonist AMD3100 prevented the effects of SDF-1 and sensitized HSC to sorafenib treatment (orangevs.blue column).Combined with the theory that CXCR4 is the unique receptor of SDF-1 [28],we could safely get the conclusion that the synergistic HSCs elimination of AMD3100 was induced by antagonizing the binding of CXCR4 and SDF-1.

    Besides,ROS-responsive drug release of ARS in HSCs was explored.It is widely reported that sorafenib could induce ROS elevation in HSCs [29],so ROS level in HSCs was used as a sorafenib release indicator.As shown in Fig.S10 (Supporting information),the control HSCs group which was activated by transforming growth factor-β(TGF-β) exhibited more ROS production than the untreated group,confirmed higher ROS content in activated HSCs.Furthermore,much more ROS was produced by HSCs in ARS group than ALS group,indicating more thorough drug release of ROS-responsive nanoparticles,which demonstrated ROS-responsive drug release of ARS at the cellular level.

    The above data have verified that the ARS nano-system not only enhanced the specific delivery efficiency to aHSCs,but also possessed synergetic effect on HSCs depletion.Therefore,this elaborate delivery system is promising for magnified liver fibrosis therapy.Subsequently,CCl4-induced liver fibrosis model was used to evaluate the therapeutic efficacy of the ARS NPs.Sorafenib loaded in different formulations,were intravenously injected to mice with CCl4-induced liver fibrosis (5 mg/kg,every other day) illustrated in Fig.4A,and alterations of some physiological indexes reflecting hepatic function were evaluated after 4-week CCl4induction.Changes in hydroxyproline (Hyp) content in the liver are considered an index of collagen metabolism and provide valuable information about the severity of liver fibrosis [30].Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are important indexes representing hepatic function and damage degree[31].According to Figs.4B-D,Hyp,AST and ALT levels significantly increased in CCl4-treated mice compared with healthy mice,indicating serious liver damage in CCl4-induced liver fibrosis.Sorafenib and AMD3100 co-delivered by final ARS NPs significantly decreased Hyp,ALT and AST compared with the model group and other treatment groups,indicating that the combination treatment may facilitate liver repair.Compared with the free drug group,the CXCR4-targeted ARS NP formulations were more effective due to the ameliorative drug delivery efficiency to aHSCs.

    Fig.4.Pharmaceutical effect of ARS in liver fibrosis.(A) Scheme illustration of CCl4 model establishment and treatment.(B-D) ALT,AST and hydroxyproline content after different treatment.(E) H&E,Masson and Sirius red staining after different treatment.(F)α-SMA immumohistochemical staining after different treatment.Scale bar=200 μm.* P <0.05,** P <0.01,*** P <0.001 vs. CCl4 model group.Results are shown as mean ± SD (n=5).

    Next,hematoxylin & eosin (H&E),Sirius red and Masson staining were used to assess the general morphology and collagen fibers of the liver.In the healthy liver,there was normal lobular architecture,with the central vein and radiating hepatic cords (Fig.4E).Otherwise,in the CCl4model group,the liver sections revealed obvious collagen fiber deposition and marked fibrosis.Marked reduction in the thickening of the collagen bundles could be observed from the Sirius red staining and Masson staining of the ARS group.

    Sustained deposition of extracellular matrix mainly results from the activation of HSCs [6].We therefore assessed the correlation between collagen accumulation and HSC activation by analyzing the expression ofα-SMA,a marker of activated HSCs,in liver tissues by immumohistochemical staining and Western blot (Fig.4F and Fig.S11 in Supporting information).The expression levels ofα-SMA were markedly higher in CCl4-treated than in healthy mice.The sorafenib alone could inhibit these pro-fibrotic factor to some extent,indicating moderate suppression of HSC activation.Excitedly,ARS delivery system combining of sorafenib plus AMD3100 significantly reducedα-SMA expression,representing the most prominent HSCs suppression and anti-fibrosis effect.

    Taken together,these results confirmed that CCl4treatment stimulated HSCs and induced the accumulation of extracellular matrix,which may facilitate or result in liver fibrosis.The ARS drug delivery platform combining of sorafenib plus AMD3100 significantly inhibited HSCs activation,induced aHSCs apoptosis and reduced liver fibrosis development.

    In conclusion,we designed a CXCR4-targeted nano-system ARS NPs based on natural and biocompatible polysaccharide and thioctic acid derivative frame.By targeting CXCR4 receptor,antagonizing SDF-1/CXCR4 axis and releasing drug on demand,ARS contributed to high delivery efficiency and selective pharmacological effects to HSCs.AMD3100 as a moiety for specific HSCs-targeting and SDF-1/CXCR4-mediated HSCs protection removal,thioctic acid derivative as a ROS-responsive cross-linker,sorafenib as a main drug for promoting apoptosis of HSCs,ARS NPs displayed a satisfied anti-fibrosis effect and provided a potential research approach for anti-fibrosis system construction.In the future,deeper intracellular mechanism of the synergistic anti-fibrosis effect of AMD3100 and sorafenib could be explored and more anti-fibrosis drug could be applied in this nano platform,which is instructive for drug delivery system design and liver fibrosis clinical therapeutics.

    Declaration of competing interest

    The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

    Acknowledgments

    This work was financially supported by the Jiangsu Agriculture Science and Technology Innovation Fund (No.CX(22)3174),the National Natural Science Foundation of China (No.82102202),Natural Science Foundation of Jiangsu Province (No.BK20210424) and Postgraduate Research & Practice Innovation Program of Jiangsu Province (No.KYCX23_0849).

    Supplementary materials

    Supplementary material associated with this article can be found,in the online version,at doi:10.1016/j.cclet.2023.108803.

    男女高潮啪啪啪动态图| e午夜精品久久久久久久| 国产一卡二卡三卡精品| 色在线成人网| 自线自在国产av| 精品电影一区二区在线| 国产精品久久电影中文字幕 | 人妻 亚洲 视频| 亚洲精品国产区一区二| 久久99一区二区三区| 亚洲一区二区三区不卡视频| 国产日韩一区二区三区精品不卡| 成熟少妇高潮喷水视频| 首页视频小说图片口味搜索| 国产精华一区二区三区| 最近最新免费中文字幕在线| 性色av乱码一区二区三区2| 成人免费观看视频高清| 深夜精品福利| 久热这里只有精品99| 成年动漫av网址| 91成人精品电影| 精品电影一区二区在线| www.自偷自拍.com| 三上悠亚av全集在线观看| 999久久久国产精品视频| 天天躁狠狠躁夜夜躁狠狠躁| 搡老岳熟女国产| 日韩成人在线观看一区二区三区| 国产欧美日韩一区二区三区在线| 久久久久久免费高清国产稀缺| 在线观看www视频免费| 老熟妇乱子伦视频在线观看| 成年人午夜在线观看视频| 曰老女人黄片| 亚洲成人免费电影在线观看| a级毛片黄视频| 少妇 在线观看| 建设人人有责人人尽责人人享有的| 一进一出抽搐gif免费好疼 | 在线观看舔阴道视频| xxx96com| 人人澡人人妻人| 丁香六月欧美| 欧美日韩国产mv在线观看视频| 老司机深夜福利视频在线观看| 一二三四在线观看免费中文在| 精品福利观看| 国产精品国产高清国产av | 中文字幕人妻丝袜制服| 狠狠婷婷综合久久久久久88av| 国产不卡av网站在线观看| 国产精品二区激情视频| 亚洲成av片中文字幕在线观看| 人妻一区二区av| 91成年电影在线观看| 欧美日韩中文字幕国产精品一区二区三区 | 精品一区二区三区视频在线观看免费 | 国产黄色免费在线视频| 最近最新中文字幕大全免费视频| 大型av网站在线播放| 久久久久久久精品吃奶| 亚洲国产欧美一区二区综合| 男女床上黄色一级片免费看| 少妇裸体淫交视频免费看高清 | 成人精品一区二区免费| 久久人妻福利社区极品人妻图片| 中文字幕人妻丝袜一区二区| 精品人妻熟女毛片av久久网站| 午夜福利乱码中文字幕| 国产一卡二卡三卡精品| 亚洲av成人av| 午夜福利在线免费观看网站| 亚洲精品中文字幕一二三四区| 久久久久久久久久久久大奶| 中国美女看黄片| 18在线观看网站| tocl精华| 日韩有码中文字幕| 久久这里只有精品19| 人妻久久中文字幕网| 男女高潮啪啪啪动态图| 精品一区二区三区av网在线观看| 色播在线永久视频| 在线十欧美十亚洲十日本专区| 三级毛片av免费| 国产亚洲欧美精品永久| 久久久国产成人精品二区 | 中国美女看黄片| 欧美日韩福利视频一区二区| 中出人妻视频一区二区| 国产有黄有色有爽视频| 日韩精品免费视频一区二区三区| 欧美激情 高清一区二区三区| 亚洲av熟女| 99久久精品国产亚洲精品| 精品国内亚洲2022精品成人 | 99re在线观看精品视频| 亚洲av熟女| 大码成人一级视频| 一级毛片高清免费大全| 在线观看www视频免费| 精品一区二区三卡| 亚洲精品美女久久久久99蜜臀| 身体一侧抽搐| 久久久国产成人精品二区 | 欧美乱妇无乱码| 免费看十八禁软件| 中文字幕人妻熟女乱码| 久久草成人影院| 最近最新中文字幕大全电影3 | 视频区图区小说| 亚洲人成伊人成综合网2020| 亚洲精品国产一区二区精华液| 丰满迷人的少妇在线观看| 免费观看精品视频网站| 在线观看舔阴道视频| 午夜激情av网站| 999久久久精品免费观看国产| 自线自在国产av| 久久精品aⅴ一区二区三区四区| 久久精品熟女亚洲av麻豆精品| 另类亚洲欧美激情| 午夜福利免费观看在线| 免费看十八禁软件| 欧美日韩视频精品一区| 国产麻豆69| 亚洲一区高清亚洲精品| av一本久久久久| 久久久久久久久免费视频了| 久久精品亚洲精品国产色婷小说| av不卡在线播放| 变态另类成人亚洲欧美熟女 | 精品一区二区三区四区五区乱码| 首页视频小说图片口味搜索| 丰满人妻熟妇乱又伦精品不卡| 国产1区2区3区精品| 亚洲中文日韩欧美视频| 免费在线观看视频国产中文字幕亚洲| 亚洲自偷自拍图片 自拍| 一二三四在线观看免费中文在| 国产精品综合久久久久久久免费 | 欧美激情极品国产一区二区三区| 国产亚洲精品久久久久5区| 国产精品成人在线| 亚洲综合色网址| 一区二区三区国产精品乱码| 亚洲va日本ⅴa欧美va伊人久久| 黄网站色视频无遮挡免费观看| 国产xxxxx性猛交| 人人妻人人爽人人添夜夜欢视频| 久久久久久久午夜电影 | 精品高清国产在线一区| 国产精品 欧美亚洲| 久久热在线av| 好看av亚洲va欧美ⅴa在| 国产精品乱码一区二三区的特点 | 亚洲欧美色中文字幕在线| 亚洲伊人色综图| 久热这里只有精品99| 天堂√8在线中文| 亚洲人成77777在线视频| cao死你这个sao货| 国产av又大| 精品久久久久久电影网| 色尼玛亚洲综合影院| 啦啦啦在线免费观看视频4| 亚洲国产欧美网| 一边摸一边抽搐一进一出视频| 天天躁夜夜躁狠狠躁躁| 精品视频人人做人人爽| 亚洲熟妇中文字幕五十中出 | 日本黄色日本黄色录像| 国产av精品麻豆| 黄片大片在线免费观看| 精品无人区乱码1区二区| 久久久久精品国产欧美久久久| 窝窝影院91人妻| 亚洲色图av天堂| 日韩制服丝袜自拍偷拍| 少妇被粗大的猛进出69影院| 久久精品人人爽人人爽视色| 在线观看午夜福利视频| 免费在线观看亚洲国产| 久久久久精品国产欧美久久久| 久久 成人 亚洲| 亚洲欧美激情在线| 极品少妇高潮喷水抽搐| 久久久久精品人妻al黑| 69av精品久久久久久| 国产成人av教育| 久久久久久久久免费视频了| 欧美激情久久久久久爽电影 | 亚洲欧美激情综合另类| 法律面前人人平等表现在哪些方面| 美女福利国产在线| 国产亚洲一区二区精品| 国产主播在线观看一区二区| 亚洲av电影在线进入| 国产精品偷伦视频观看了| 亚洲成国产人片在线观看| 精品一区二区三区av网在线观看| 97人妻天天添夜夜摸| 色在线成人网| 女性生殖器流出的白浆| 欧美乱妇无乱码| 国产精品 欧美亚洲| 两性午夜刺激爽爽歪歪视频在线观看 | 热99久久久久精品小说推荐| 视频区欧美日本亚洲| 男人的好看免费观看在线视频 | 亚洲成av片中文字幕在线观看| 最近最新免费中文字幕在线| 国产成人免费观看mmmm| 国产成人av激情在线播放| 在线观看66精品国产| 午夜福利视频在线观看免费| 国产欧美亚洲国产| 日韩人妻精品一区2区三区| 最新在线观看一区二区三区| 人妻丰满熟妇av一区二区三区 | 在线永久观看黄色视频| 亚洲av第一区精品v没综合| 无人区码免费观看不卡| 人妻丰满熟妇av一区二区三区 | 热99久久久久精品小说推荐| 在线看a的网站| 国产成人免费观看mmmm| 精品国内亚洲2022精品成人 | 一本一本久久a久久精品综合妖精| 99国产精品一区二区蜜桃av | 精品电影一区二区在线| 久久中文看片网| 桃红色精品国产亚洲av| 国产男女内射视频| 老熟妇乱子伦视频在线观看| av中文乱码字幕在线| 久久精品人人爽人人爽视色| 免费观看a级毛片全部| 亚洲色图综合在线观看| 亚洲熟女毛片儿| 午夜福利一区二区在线看| 极品教师在线免费播放| 欧美日韩福利视频一区二区| 国产激情欧美一区二区| 久久精品亚洲精品国产色婷小说| 国产无遮挡羞羞视频在线观看| 久久国产精品影院| 免费少妇av软件| 亚洲av电影在线进入| 69精品国产乱码久久久| 丰满迷人的少妇在线观看| 两性午夜刺激爽爽歪歪视频在线观看 | 丰满迷人的少妇在线观看| 亚洲中文字幕日韩| 午夜福利一区二区在线看| 又大又爽又粗| 国产高清国产精品国产三级| 欧美精品啪啪一区二区三区| 中文字幕制服av| 另类亚洲欧美激情| 久久久久久久精品吃奶| 久久久国产成人精品二区 | 日日爽夜夜爽网站| 黑人巨大精品欧美一区二区mp4| 国产高清激情床上av| 亚洲中文av在线| 日本一区二区免费在线视频| 国产激情欧美一区二区| 亚洲精品成人av观看孕妇| 一级a爱片免费观看的视频| 免费女性裸体啪啪无遮挡网站| 亚洲成国产人片在线观看| 亚洲av成人一区二区三| 一级黄色大片毛片| 久热这里只有精品99| 亚洲七黄色美女视频| 国产亚洲欧美精品永久| 两性午夜刺激爽爽歪歪视频在线观看 | 男女下面插进去视频免费观看| 人妻久久中文字幕网| 在线观看www视频免费| 亚洲中文av在线| 久久久久国产一级毛片高清牌| 免费日韩欧美在线观看| 久久狼人影院| av超薄肉色丝袜交足视频| 50天的宝宝边吃奶边哭怎么回事| 午夜视频精品福利| 黄色视频,在线免费观看| 精品久久久久久电影网| 美女福利国产在线| 午夜精品国产一区二区电影| 国产免费现黄频在线看| 在线观看日韩欧美| 热re99久久国产66热| 精品人妻1区二区| 视频区欧美日本亚洲| 久99久视频精品免费| 国产激情欧美一区二区| 女人被躁到高潮嗷嗷叫费观| 亚洲精品国产精品久久久不卡| 久9热在线精品视频| 久久青草综合色| 身体一侧抽搐| 深夜精品福利| 国产熟女午夜一区二区三区| 欧美最黄视频在线播放免费 | 怎么达到女性高潮| 国产欧美日韩一区二区三区在线| 大香蕉久久网| 亚洲免费av在线视频| 一本大道久久a久久精品| 色在线成人网| 在线看a的网站| 免费av中文字幕在线| 激情视频va一区二区三区| www.999成人在线观看| 操出白浆在线播放| 王馨瑶露胸无遮挡在线观看| 色在线成人网| 久久99一区二区三区| 欧美日韩亚洲国产一区二区在线观看 | 美国免费a级毛片| 精品视频人人做人人爽| 国产av又大| 亚洲 欧美一区二区三区| 国产精品影院久久| 成在线人永久免费视频| 国产成人欧美在线观看 | 国产精品av久久久久免费| 一级片'在线观看视频| 国产精品一区二区精品视频观看| 亚洲,欧美精品.| 波多野结衣一区麻豆| 成人精品一区二区免费| 波多野结衣av一区二区av| 久久99一区二区三区| 欧美中文综合在线视频| 亚洲精品在线美女| 亚洲性夜色夜夜综合| 首页视频小说图片口味搜索| 亚洲色图av天堂| 欧美激情 高清一区二区三区| av福利片在线| 一本大道久久a久久精品| 精品一品国产午夜福利视频| 男人的好看免费观看在线视频 | 色精品久久人妻99蜜桃| 亚洲 欧美一区二区三区| av天堂在线播放| 亚洲国产欧美一区二区综合| 男女高潮啪啪啪动态图| 国产99白浆流出| 国产男女超爽视频在线观看| 亚洲精品乱久久久久久| 久久国产精品影院| 捣出白浆h1v1| 首页视频小说图片口味搜索| 曰老女人黄片| 国产精品二区激情视频| 亚洲欧美激情综合另类| 曰老女人黄片| 亚洲久久久国产精品| 国产成人免费观看mmmm| 97人妻天天添夜夜摸| 国产精品免费一区二区三区在线 | 亚洲av成人一区二区三| 啦啦啦免费观看视频1| 一区二区三区精品91| 窝窝影院91人妻| 波多野结衣av一区二区av| 日韩大码丰满熟妇| 啦啦啦在线免费观看视频4| 亚洲国产看品久久| 久久性视频一级片| 久久国产亚洲av麻豆专区| 国产一区有黄有色的免费视频| 日韩 欧美 亚洲 中文字幕| av超薄肉色丝袜交足视频| 亚洲情色 制服丝袜| 久久人人97超碰香蕉20202| 亚洲一码二码三码区别大吗| 色婷婷av一区二区三区视频| 欧美精品亚洲一区二区| 18禁国产床啪视频网站| 免费在线观看黄色视频的| 欧美人与性动交α欧美软件| 免费在线观看完整版高清| 亚洲人成伊人成综合网2020| 97人妻天天添夜夜摸| 欧美激情极品国产一区二区三区| 成年女人毛片免费观看观看9 | videos熟女内射| 黄频高清免费视频| 久久人妻av系列| 韩国精品一区二区三区| 午夜福利在线观看吧| 看片在线看免费视频| 亚洲片人在线观看| 国产熟女午夜一区二区三区| 黑人操中国人逼视频| 91麻豆精品激情在线观看国产 | 中文字幕色久视频| 国产亚洲av高清不卡| 19禁男女啪啪无遮挡网站| 久久久久国产一级毛片高清牌| 精品国产超薄肉色丝袜足j| 亚洲欧美一区二区三区黑人| 高潮久久久久久久久久久不卡| 村上凉子中文字幕在线| 亚洲一区二区三区欧美精品| 91精品国产国语对白视频| 一进一出好大好爽视频| 老司机午夜十八禁免费视频| 欧美日韩av久久| 99精国产麻豆久久婷婷| 精品国产乱子伦一区二区三区| 国产精品久久久av美女十八| 91国产中文字幕| 成年人午夜在线观看视频| 久久香蕉国产精品| 美女扒开内裤让男人捅视频| 嫩草影视91久久| 丝袜人妻中文字幕| 韩国av一区二区三区四区| 国产91精品成人一区二区三区| 色婷婷av一区二区三区视频| 亚洲欧美精品综合一区二区三区| 午夜福利在线免费观看网站| 男女高潮啪啪啪动态图| 乱人伦中国视频| 如日韩欧美国产精品一区二区三区| 欧美精品人与动牲交sv欧美| 欧美日韩亚洲国产一区二区在线观看 | 九色亚洲精品在线播放| 亚洲男人天堂网一区| 在线av久久热| 国产精品久久久久久精品古装| 国产成人精品无人区| 脱女人内裤的视频| 国产不卡一卡二| 无人区码免费观看不卡| 亚洲色图av天堂| 国产精品.久久久| 成人国语在线视频| 黑人操中国人逼视频| 久久精品aⅴ一区二区三区四区| 日本一区二区免费在线视频| 麻豆乱淫一区二区| 久久人妻福利社区极品人妻图片| 精品少妇久久久久久888优播| 亚洲国产看品久久| 日韩一卡2卡3卡4卡2021年| 免费在线观看影片大全网站| a级毛片在线看网站| 两性午夜刺激爽爽歪歪视频在线观看 | av一本久久久久| 国产一区有黄有色的免费视频| 久9热在线精品视频| av免费在线观看网站| 久久中文字幕人妻熟女| 淫妇啪啪啪对白视频| av视频免费观看在线观看| 久久久久视频综合| 精品电影一区二区在线| 国产av又大| 精品少妇一区二区三区视频日本电影| 大陆偷拍与自拍| 久久国产亚洲av麻豆专区| 欧美激情 高清一区二区三区| 欧美中文综合在线视频| 午夜福利视频在线观看免费| 精品无人区乱码1区二区| 身体一侧抽搐| 1024视频免费在线观看| 久久精品亚洲熟妇少妇任你| 美女高潮到喷水免费观看| 久久影院123| 国产精品久久久人人做人人爽| 免费不卡黄色视频| 12—13女人毛片做爰片一| 视频在线观看一区二区三区| 两性午夜刺激爽爽歪歪视频在线观看 | 国产激情久久老熟女| 无遮挡黄片免费观看| 午夜老司机福利片| 999精品在线视频| 亚洲国产欧美一区二区综合| 成人永久免费在线观看视频| 亚洲男人天堂网一区| 成人18禁在线播放| 日韩成人在线观看一区二区三区| 久99久视频精品免费| 亚洲熟女毛片儿| a级毛片在线看网站| 色老头精品视频在线观看| 久久国产精品大桥未久av| 久久国产亚洲av麻豆专区| 18禁国产床啪视频网站| 亚洲国产中文字幕在线视频| 亚洲美女黄片视频| bbb黄色大片| 12—13女人毛片做爰片一| 99香蕉大伊视频| 老司机靠b影院| 亚洲人成电影免费在线| 久久久久久免费高清国产稀缺| 麻豆av在线久日| 精品卡一卡二卡四卡免费| 一本一本久久a久久精品综合妖精| 久久国产精品人妻蜜桃| 日韩欧美三级三区| 嫁个100分男人电影在线观看| 亚洲av片天天在线观看| 高清视频免费观看一区二区| 国产激情久久老熟女| 欧美在线黄色| 成人三级做爰电影| 美女午夜性视频免费| 女警被强在线播放| 久久久久国产精品人妻aⅴ院 | 免费不卡黄色视频| 乱人伦中国视频| 久久久精品国产亚洲av高清涩受| 女性被躁到高潮视频| 91麻豆精品激情在线观看国产 | 人人妻人人澡人人看| 又黄又爽又免费观看的视频| 91av网站免费观看| 少妇猛男粗大的猛烈进出视频| 国产欧美日韩精品亚洲av| 久久国产精品人妻蜜桃| 久久天堂一区二区三区四区| 免费av中文字幕在线| 精品人妻在线不人妻| av一本久久久久| 国产欧美日韩一区二区三| 高清在线国产一区| 欧美午夜高清在线| av一本久久久久| 宅男免费午夜| 精品一区二区三区av网在线观看| 免费在线观看完整版高清| 欧美久久黑人一区二区| 18禁国产床啪视频网站| 国产精品一区二区在线不卡| 久久久精品免费免费高清| 国产精品欧美亚洲77777| 国产欧美日韩一区二区三| 久久国产精品人妻蜜桃| 99精品欧美一区二区三区四区| 正在播放国产对白刺激| 国产欧美日韩一区二区三| 国产aⅴ精品一区二区三区波| 亚洲第一青青草原| 亚洲在线自拍视频| 男女床上黄色一级片免费看| 人妻丰满熟妇av一区二区三区 | 成人手机av| 一区二区三区激情视频| 国产色视频综合| av免费在线观看网站| 午夜福利在线观看吧| 在线观看www视频免费| 国产欧美日韩一区二区精品| 女人被躁到高潮嗷嗷叫费观| 一区在线观看完整版| 男人舔女人的私密视频| 人人妻人人澡人人看| 久久精品国产a三级三级三级| 操美女的视频在线观看| 极品少妇高潮喷水抽搐| 成年女人毛片免费观看观看9 | 大型av网站在线播放| 亚洲一区中文字幕在线| 国产精品久久视频播放| 亚洲欧美日韩另类电影网站| 在线观看免费日韩欧美大片| 丝袜在线中文字幕| 国产成人av教育| 免费黄频网站在线观看国产| 少妇的丰满在线观看| 丁香欧美五月| 国产精品免费大片| 一区福利在线观看| 亚洲情色 制服丝袜| 久久久久久久午夜电影 | 亚洲va日本ⅴa欧美va伊人久久| 满18在线观看网站| 精品少妇一区二区三区视频日本电影| 国产色视频综合| 男人舔女人的私密视频| 国产亚洲欧美98| 国产精品香港三级国产av潘金莲| 国产男女内射视频| 国产av一区二区精品久久| 久久人妻av系列| 99国产精品免费福利视频| 美女福利国产在线| 国产亚洲精品久久久久5区| 亚洲国产精品合色在线| 国产黄色免费在线视频| 国产成人欧美| 99久久精品国产亚洲精品| 午夜福利视频在线观看免费| 亚洲avbb在线观看| 国产一卡二卡三卡精品| 国产精品电影一区二区三区 | 啦啦啦在线免费观看视频4| 91成年电影在线观看| 欧美人与性动交α欧美软件| a级毛片在线看网站| 婷婷成人精品国产| 精品久久久久久电影网|